| Matti W Palo Jr, MD | |
|
70411 Highway 21, Covington, LA 70433-8103 | |
| (985) 400-5566 | |
| (985) 400-5560 |
| Full Name | Matti W Palo Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 26 Years |
| Location | 70411 Highway 21, Covington, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013949619 | NPI | - | NPPES |
| 04233229 | Medicaid | MS | |
| 1572713 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD.025221 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vital Link, A Home Care Company | Hammond, LA | Home health agency |
| Avala | Covington, LA | Hospital |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Joint Efforts Llc | 9234552241 | 7 |
News Archive
Unusually high levels of physical exertion do cause oxidative stress, but this does not result in any long-term damage to DNA. This is just one of the many outcomes revealed by an extraordinary research project funded by the Austrian Science Fund FWF that are now published. As part of this project, 42 male athletes took part both in a triathlon and an extensive biomedical study, which examined numerous physiological values parameters during the period from two days before to 19 days after the triathlon.
The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopedic surgery requiring immobilization in comparison with enoxaparin, another anticoagulant agent, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
"On World AIDS Day, the fact that the number of children newly infected with HIV continues to decline is welcome news to UNITAID, the international drug purchase facility hosted by the World Health Organization," Inter Press Service reports, adding, "But UNITAID is also well aware of how much more remains to be done for children already living with the disease."
Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.
› Verified 3 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Unusually high levels of physical exertion do cause oxidative stress, but this does not result in any long-term damage to DNA. This is just one of the many outcomes revealed by an extraordinary research project funded by the Austrian Science Fund FWF that are now published. As part of this project, 42 male athletes took part both in a triathlon and an extensive biomedical study, which examined numerous physiological values parameters during the period from two days before to 19 days after the triathlon.
The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopedic surgery requiring immobilization in comparison with enoxaparin, another anticoagulant agent, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
"On World AIDS Day, the fact that the number of children newly infected with HIV continues to decline is welcome news to UNITAID, the international drug purchase facility hosted by the World Health Organization," Inter Press Service reports, adding, "But UNITAID is also well aware of how much more remains to be done for children already living with the disease."
Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.
› Verified 3 days ago
| Entity Name | Joint Efforts Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730704370 PECOS PAC ID: 9234552241 Enrollment ID: O20200709001902 |
News Archive
Unusually high levels of physical exertion do cause oxidative stress, but this does not result in any long-term damage to DNA. This is just one of the many outcomes revealed by an extraordinary research project funded by the Austrian Science Fund FWF that are now published. As part of this project, 42 male athletes took part both in a triathlon and an extensive biomedical study, which examined numerous physiological values parameters during the period from two days before to 19 days after the triathlon.
The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopedic surgery requiring immobilization in comparison with enoxaparin, another anticoagulant agent, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
"On World AIDS Day, the fact that the number of children newly infected with HIV continues to decline is welcome news to UNITAID, the international drug purchase facility hosted by the World Health Organization," Inter Press Service reports, adding, "But UNITAID is also well aware of how much more remains to be done for children already living with the disease."
Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matti W Palo Jr, MD 5959 S Sherwood Forest Blvd, Baton Rouge, LA 70816-6038 Ph: (225) 765-5727 | Matti W Palo Jr, MD 70411 Highway 21, Covington, LA 70433-8103 Ph: (985) 400-5566 |
News Archive
Unusually high levels of physical exertion do cause oxidative stress, but this does not result in any long-term damage to DNA. This is just one of the many outcomes revealed by an extraordinary research project funded by the Austrian Science Fund FWF that are now published. As part of this project, 42 male athletes took part both in a triathlon and an extensive biomedical study, which examined numerous physiological values parameters during the period from two days before to 19 days after the triathlon.
The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopedic surgery requiring immobilization in comparison with enoxaparin, another anticoagulant agent, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
"On World AIDS Day, the fact that the number of children newly infected with HIV continues to decline is welcome news to UNITAID, the international drug purchase facility hosted by the World Health Organization," Inter Press Service reports, adding, "But UNITAID is also well aware of how much more remains to be done for children already living with the disease."
Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.
› Verified 3 days ago
Dr. Jeremy R James, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 76 Starbrush Cir, Covington, LA 70433 Phone: 985-400-5778 Fax: 985-888-1042 | |
Daniel Sinclair, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 19343 Sunshine Ave, Covington, LA 70433 Phone: 985-892-5117 Fax: 985-892-5128 | |
Khader Samer-fayez Shamieh, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 76 Starbrush Cir, Covington, LA 70433 Phone: 844-800-3472 | |
Herbert R Plauche, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 19343 Sunshine Ave, Covington, LA 70433 Phone: 985-892-5117 Fax: 985-892-5128 | |
Joseph Bonvillain, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 19343 Sunshine Ave, Covington, LA 70433 Phone: 985-892-5117 Fax: 985-892-5128 | |
Dr. Mark James Hontas, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 71211 Highway 21, Covington, LA 70433 Phone: 985-893-9922 Fax: 985-892-3806 |